Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin’s Lymphoma

dc.TypeArticlept_BR
dc.contributor.authorComber, Harry
dc.contributor.authorCancela, Marianna de Camargo
dc.contributor.authorJohnson, Howard
dc.contributor.authorSharp, Linda
dc.contributor.authorPratschke, Jonathan
dc.contributor.authorHaase, Trutz
dc.date.accessioned2022-07-18T17:08:15Z
dc.date.available2022-07-18T17:08:15Z
dc.date.issued2016
dc.descriptionv. 11, n. 12. 2016pt_BR
dc.description.abstractBackground The aim of this study was to investigate inequalities in survival for non-Hodgkin’s lymphoma (NHL), distinguishing between direct and indirect effects of patient, social and process-ofcare factors. Methods All cases of NHL diagnosed in Ireland in 2004–2008 were included. Variables describing patient, cancer, stage and process of care were included in a discrete-time model of survival using Structural Equation Modelling software. Results Emergency admissions were more common in patients with co-morbid conditions or with more aggressive cancers, and less frequent for patients from more affluent areas. Aggressive morphology, female sex, emergency admission, increasing age, comorbidity, treatment in a high caseload hospital and late stage were associated with increased hazard of mortality. Private patients had a reduced hazard of mortality, mediated by systemic therapy, admission to high caseload hospitals and fewer emergency admissions. Discussion The higher rate of emergency presentation, and consequent poorer survival, of uninsured patients, suggests they face barriers to early presentation. Social, educational and cultural factors may also discourage disadvantaged patients from consulting with early symptoms of NHL. Non-insured patients, who present later and have more emergency admissions would benefit from better access to diagnostic services. Older patients remain disadvantaged by sub-optimal treatment, treatment in non-specialist centres and emergency admission.pt_BR
dc.identifier.citationComber H, De Camargo Cancela M, Haase T, Johnson H, Sharp L, Pratschke J. Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin’s Lymphoma. PLoS ONE v. 11, n. 12. 2016. Disponível em: doi:10.1371/journal.pone.0168684pt_BR
dc.identifier.issn1932-6203
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/9265
dc.language.isoenpt_BR
dc.publisherPlos onept_BR
dc.subjectDoença de Hodgkinpt_BR
dc.subjectHodgkin Diseasept_BR
dc.subjectEnfermedad de Hodgkinpt_BR
dc.subjectDiagnóstico Tardiopt_BR
dc.subjectDelayed Diagnosispt_BR
dc.subjectDiagnóstico Tardíopt_BR
dc.subjectCuidados Médicospt_BR
dc.subjectMedical Carept_BR
dc.subjectAtención Médicapt_BR
dc.titleAffluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin’s Lymphomapt_BR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkins Lymphoma - 2016.pdf
Size:
950.78 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description: